PETALING JAYA: US President Donald Trump has threatened to impose a 200% tariff on pharmaceutical imports into the United States, and while global pharma giants are awaiting further developments, stakeholders anticipate a minimal impact on Malaysia at this juncture.
While Malaysia is facing 25% tariffs on various exports to the US, the impact from this industry remains uncertain, leaving the government, particularly the Health Ministry, sourcing for alternatives to mitigate the supply chain.
